Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Jan;79(1):47–53. doi: 10.1111/j.1365-2249.1990.tb05125.x

Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis.

G Ferraro 1, P L Meroni 1, A Tincani 1, A Sinico 1, W Barcellini 1, A Radice 1, G Gregorini 1, M Froldi 1, M O Borghi 1, G Balestrieri 1
PMCID: PMC1534732  PMID: 2302834

Abstract

Anti-endothelial cell antibodies (AECA) have been detected by cell surface radioimmunoassay in nine out of 15 patients with micropolyarteritis (MPA) and in two out of five patients with Wegener's granulomatosis. AECA mostly belonged to the IgG isotype and were present in the active phase of the diseases. These antibodies were not detectable in 10 sera from patients with essential mixed cryoglobulinaemia, suggesting that they were not a mere epiphenomenon consequent to the inflammatory vascular injury. The binding activity was not related to ABH antigens or to HLA class I antigens displayed by resting human endothelial cells in culture and was not influenced by removing immune complexes. Absorption of the anti-neutrophil cytoplasmic antibodies (ANCA), present in MPA and Wegener's granulomatosis sera, did not affect the endothelial binding. AECA-positive sera did not display lytic activity against endothelial cells, neither alone nor after addition of fresh complement or normal human peripheral blood mononuclear cells. Although AECA are not cytolytic for endothelial cell monolayers in vitro, the reactivity against intact endothelial cells suggests their possible involvement in in vivo pathological processes affecting vascular structures in small vessel primary vasculitides.

Full text

PDF
47

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott F., Jones S., Lockwood C. M., Rees A. J. Autoantibodies to glomerular antigens in patients with Wegener's granulomatosis. Nephrol Dial Transplant. 1989;4(1):1–8. [PubMed] [Google Scholar]
  2. Brouet J. C., Clauvel J. P., Danon F., Klein M., Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974 Nov;57(5):775–788. doi: 10.1016/0002-9343(74)90852-3. [DOI] [PubMed] [Google Scholar]
  3. Capsoni F., Meroni P. L., Zocchi M. R., Plebani A. M., Vezio M. Effect of corticosteroids on neutrophil function: inhibition of antibody-dependent cell mediated cytotoxicity (ADCC). J Immunopharmacol. 1983;5(3):217–230. doi: 10.3109/08923978309039107. [DOI] [PubMed] [Google Scholar]
  4. Cotran R. S., Gimbrone M. A., Jr, Bevilacqua M. P., Mendrick D. L., Pober J. S. Induction and detection of a human endothelial activation antigen in vivo. J Exp Med. 1986 Aug 1;164(2):661–666. doi: 10.1084/jem.164.2.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983 Jan;98(1):76–85. doi: 10.7326/0003-4819-98-1-76. [DOI] [PubMed] [Google Scholar]
  6. Fauci A. S., Haynes B., Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med. 1978 Nov;89(5 Pt 1):660–676. doi: 10.7326/0003-4819-89-5-660. [DOI] [PubMed] [Google Scholar]
  7. Horneland M., Rekvig O. P., Jørgensen L., Hannestad K. Cultured human endothelial cells display an antigen that is recognized by certain human anti-chromatin autoantibodies. Clin Exp Immunol. 1983 Nov;54(2):373–377. [PMC free article] [PubMed] [Google Scholar]
  8. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kahaleh M. B., Osborn I., LeRoy E. C. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. Ann Intern Med. 1981 Apr;94(4 Pt 1):482–484. doi: 10.7326/0003-4819-94-4-482. [DOI] [PubMed] [Google Scholar]
  10. Leung D. Y., Geha R. S., Newburger J. W., Burns J. C., Fiers W., Lapierre L. A., Pober J. S. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med. 1986 Dec 1;164(6):1958–1972. doi: 10.1084/jem.164.6.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leung D. Y., Moake J. L., Havens P. L., Kim M., Pober J. S. Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome. Lancet. 1988 Jul 23;2(8604):183–186. doi: 10.1016/s0140-6736(88)92287-8. [DOI] [PubMed] [Google Scholar]
  12. Meroni P. L., Barcellini W., DeBartolo G., Invernizzi F., Zanussi C. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from patients with essential mixed cryoglobulinemia. Clin Immunol Immunopathol. 1984 Nov;33(2):245–257. doi: 10.1016/0090-1229(84)90079-5. [DOI] [PubMed] [Google Scholar]
  13. Meroni P. L., de Bartolo G., Barcellini W., Riboldi P. S., Basile R., Betterle C., Zanussi C. Anti-ribosomal ribonucleoprotein autoantibodies in systemic lupus erythematosus. J Clin Immunol. 1984 Jan;4(1):45–54. doi: 10.1007/BF00915287. [DOI] [PubMed] [Google Scholar]
  14. Moraes J. R., Stastny P. A new antigen system expressed in human endothelial cells. J Clin Invest. 1977 Aug;60(2):449–454. doi: 10.1172/JCI108795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nusinow S. R., Federici A. B., Zimmerman T. S., Curd J. G. Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthritis Rheum. 1984 Dec;27(12):1405–1410. doi: 10.1002/art.1780271211. [DOI] [PubMed] [Google Scholar]
  16. Penning C. A., Cunningham J., French M. A., Harrison G., Rowell N. R., Hughes P. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol. 1984 Sep;57(3):548–556. [PMC free article] [PubMed] [Google Scholar]
  17. Penning C. A., French M. A., Rowell N. R., Hughes P. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus. J Clin Lab Immunol. 1985 Jul;17(3):125–130. [PubMed] [Google Scholar]
  18. Savage C. O., Winearls C. G., Evans D. J., Rees A. J., Lockwood C. M. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med. 1985 Aug;56(220):467–483. [PubMed] [Google Scholar]
  19. Savage C. O., Winearls C. G., Jones S., Marshall P. D., Lockwood C. M. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet. 1987 Jun 20;1(8547):1389–1393. doi: 10.1016/s0140-6736(87)90591-5. [DOI] [PubMed] [Google Scholar]
  20. Tannenbaum S. H., Finko R., Cines D. B. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol. 1986 Sep 1;137(5):1532–1537. [PubMed] [Google Scholar]
  21. Tincani A., Meroni P. L., Brucato A., Zanussi C., Allegri F., Mantelli P., Cattaneo R., Balestrieri G. Anti-phospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus. Clin Exp Rheumatol. 1985 Oct-Dec;3(4):321–326. [PubMed] [Google Scholar]
  22. Tuddenham E. G., Lazarchick J., Hoyer L. W. Synthesis and release of factor VIII by cultured human endothelial cells. Br J Haematol. 1981 Apr;47(4):617–626. doi: 10.1111/j.1365-2141.1981.tb02691.x. [DOI] [PubMed] [Google Scholar]
  23. Vismara A., Meroni P. L., Tincani A., Harris E. N., Barcellini W., Brucato A., Khamashta M., Hughes G. R., Zanussi C., Balestrieri G. Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol. 1988 Nov;74(2):247–253. [PMC free article] [PubMed] [Google Scholar]
  24. Woolf A. D., Wakerley G., Wallington T. B., Scott D. G., Dieppe P. A. Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis. 1987 Jun;46(6):441–447. doi: 10.1136/ard.46.6.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Yap H. K., Sakai R. S., Bahn L., Rappaport V., Woo K. T., Ananthurman V., Lim C. H., Chiang G. S., Jordan S. C. Anti-vascular endothelial cell antibodies in patients with IgA nephropathy: frequency and clinical significance. Clin Immunol Immunopathol. 1988 Dec;49(3):450–462. doi: 10.1016/0090-1229(88)90132-8. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES